Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Benitec Biopharma Ltd (NASDAQ:BNTC)

2.96
Delayed Data
As of 3:59pm ET
 +0.1952 / +7.06%
Today’s Change
1.30
Today|||52-Week Range
5.48
+93.46%
Year-to-Date
No recent news for Benitec Biopharma Ltd.

Today’s Trading

Previous close2.76
Today’s open2.86
Day’s range2.85 - 2.99
Volume26,570
Average volume (3 months)60,668
Market cap$28.4M
Data as of 3:59pm ET, 12/18/2017

Growth & Valuation

Earnings growth (last year)+80.71%
Earnings growth (this year)-579.01%
Earnings growth (next 5 years)--
Revenue growth (last year)+39.72%
P/E ratioNM
Price/Sales64.62
Price/Book1.72

Competitors

 Today’s
change
Today’s
% change
PTIEPain Therapeutics In...+0.01+0.24%
----
DRIODarioHealth Corp+0.15+10.00%
ONSOncobiologics Inc+0.03+2.59%
Data as of 4:00pm ET, 12/18/2017

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$251.1K
Annual profit (last year)-$4.3M
Net profit margin-1,708.71%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Secretary
Gregory C. West
Chief Operating &
Business Officer
Cliff Holloway
Corporate headquarters
North Sydney, New South Wales (nsw)

Forecasts